Barnes Group Other Non-Current Liabilities increased by 33.2% to $94.96M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 112.6%, from $44.67M to $94.96M. Over 3 years (FY 2020 to FY 2023), Other Non-Current Liabilities shows an upward trend with a 17.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.31M | $40.02M | $42.13M | $43.65M | $40.11M | $35.65M | $36.69M | $36.41M | $36.02M | $44.67M | $80.87M | $77.14M | $71.30M | $94.96M |
| QoQ Change | — | -23.5% | +5.3% | +3.6% | -8.1% | -11.1% | +2.9% | -0.8% | -1.1% | +24.0% | +81.0% | -4.6% | -7.6% | +33.2% |
| YoY Change | — | — | — | — | -23.3% | -10.9% | -12.9% | -16.6% | -10.2% | +25.3% | +120.4% | +111.9% | +98.0% | +112.6% |